By Dan Stanton+, 11-May-2015
Recent US FDA approval of products containing the excipient HPC has driven demand, according to Nippon Soda (Nisso) which has expanded its production facility in Japan.
http://www.in-pharmatechnologist.com/Ingredients/Nisso-opens-expanded-HPC-plant-on-back-of-pharma-demand